Differential expression of inducible nitric oxide synthase messenger rna along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats

Critical Care Medicine

Volumn 26, Issue 7, 1998, Pages 1258-1264

  Morin, Melinda J ^a   Unno, Naoki ^a   Hodin, Richard A ^a   Fink, Mitchell P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Endotoxin; Enterocyte; Epithel ium, intestinal; Inducible; Lipopolysaccharide; LPS; Nitric oxide; Nitric oxide synthase; Sepsis

Indexed keywords

CYCLOHEXIMIDE; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; INTESTINE CRYPT; INTESTINE VILLUS; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0031867470     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199807000-00031     Document Type: Article

References (63)

1. Fink MP: Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 1991; 19:627-641
2. Pons L, Droy-Lefaix MT, Braquet P, et al: Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats. Gastroenterology 1991; 100:946-953
3. László F, Whittle BJR, Moncada S: Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol 1994; 113:1131-1136
4. Ciancio MJ, Vitiritti L, Dhar A, et al: Endotoxin-induced alterations in rat colonie water and electrolyte transport. Gastroenterology 1992; 103:1431-1443
5. Deitch EA, Specian RD, Berg RD: Endotoxin-induced bacterial translocation and mucosal permeability: Role of xanthine oxidase, complement activation, and macrophage products. Crit Care Med 1991; 19:785-791
6. Fink MP, Antonsson JB, Wang H, et al: Increased intestinal permeability in endotoxic pigs: Mesenteric hypoperfusion as an etiologic factor. Arch Surg 1991; 126:211-218
7. Tepperman BL, Brown JF, Whittle BJR: Nitric oxide synthase induction and intestinal cell viability in rats. Am J Physiol 1993; 265:G214-G218
8. Tepperman BL, Brown JF, Korolkiewicz R, et al: Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonie epithelial cells: Effect of endotoxin challenge. J Pharmacol Exp Ther 1994; 271:1477-1482
9. Fink MP, Kaups KL, Wang H, et al: Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery 1991; 110: 154-161
10. Xu D, Lu Q, Guillory D, et al: Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 1993; 34:676-683
11. Salzman AL, Wang H, Wollert PS, et al: Endotoxin-induced ileal mucosal hyperpermeability in pigs: Role of tissue acidosis. Am J Physiol 1994; 266:G633-G646
12. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051-3064
13. Stuehr DJ, Griffith OW: Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1994; 65:287-346
14. Meyer J, Traber LD, Nelson S, et al: Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 1992; 73:324-328
15. Brooke M, Hinder F, Traber LD, et al: S-ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep. Shock 1995; 4:274-281
16. Julou-Schaeffer G, Gray GA, Fleming I, et al: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259:H1038-H1043
17. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with Smethylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A 1994; 91:12472-12476
18. Brady AJB, Poole-Wilson PA, Harding SE, et al: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992; 263:H1963-H1966
19. Herbertson MJ, Werner HA, Walley KR: Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am J Physiol 1996; 270:H1979-H1984
20. Hinder F, Booke M, Traber LD, et al: Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit Care Med 1996; 24: 131-136
21. Molina L, Studenberg S, Wolberg G, et al: Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli. J Clin Invest 1996; 98:192-198
22. Aranow JS, Zhuang J, Wang H, et al: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies. Shock 1996; 5:116-121
23. 12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: Role of nitric oxide. J Pharmacol Exp Ther 1995; 273:257-265
24. Tsuji Y, Unno N, Menconi MJ, et al: Nitric oxide donors increase cytosolic ionized calcium in cultured human intestinal epithelial cells. Shock 1996; 6:19-24
25. Salzman AL, Menconi MJ, Unno N, et al: Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 1995; 268:G361-G373
26. Burnier M, Waeber B, Aubert JF, et al: Effect of nonhypotensive endotoxemia in conscious rats: Role of prostaglandins. Am J Physiol 1988; 254: H509-H605
27. Voisin T, Rouyer-Fessard C, Laburthe M: Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal crypt-villus axis. Am J Physiol 1990; 258:G753-G759
28. Chirgwin JM, Pryzbla AE, MacDonald RJ, et al: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1998; 18:5294-5299
29. Maniatis J, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989
30. 1-acid-glycoprotein, apolipoprotein E, apolipoprotein B, and β-actin after mouse recombinant tumor necrosis factor injection. Biochem Biophys Res Commun 1989; 161:81-88
31. Kohno H, Hamanaka R, Abe T, et al: Morphological change and destabilization of β-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp Cell Res 1993; 208:498-503
32. Feinberg AP, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragment to high specific activity. Anal Biochem 1983; 132: 6-13
33. Geller DA, Lowenstein C, Shapiro RA, et al: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 1993; 90:3491-3495
34. Oullette AJ, Lualdi JC: A novel mouse gene family coding for cationic, cysteine-rich peptides. J Biol Chem 1990; 265:9831-9837
35. Buller HA, Kothe MJC, Goldman DA, et al: Coordinate expression of lactate-phlorizin hydrolase mRNA and enzyme levels in rat intestine during development. J Biol Chem 1990; 265: 6978-6983
36. Miller AD, Curran T, Verma IM: c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene. Cell 1984; 36: 51-60
37. Edwards DR, Mahadevan LC: Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: Lack of evidence for labile repressors. EMBO J 1992; 11:2415-2424
38. Xie QW, Cho HJ, Calaycay J, et al: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-228
39. Weinberg JB, Misukonis MA, Shami PJ, et al: Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995; 86: 1184-1195
40. Nicholson SC, Bonecini-Almeida MD, Lapa e Silva JR, et al: Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183: 2293-2302
41. Archer SL, Freude KA, Shultz PJ: Effect of graded hypoxia on the induction and function of inducible nitric oxide synthase in rat mesangial cells. Circ Res 1995; 77:21-28
42. Haywood GA, Tsao PS, von der Leyen HE, et al: Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996; 93: 1087-1094
43. Singh K, Balligand J-L, Fischer TA, et al: Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in the regulation of inducible nitric oxide synthase. J Biol Chem 1995; 270: 28471-28478
44. Geng Y-j, Almqvist M, Hansson GK: cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochem Biophys Acta 1994; 1218:421-424
45. MacNaul KL, Hutchinson NI: Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993; 196:1330-1334
46. Karlsen AE, Andersen HU, Vissing H, et al: Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 1995; 44:753-758
47. Nussler AK, Di Silvio M, Liu ZZ, et al: Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology 1996; 21:1552-1560
48. Arnoah-Apraku B, Chandler LJ, Harrison JK, et al: NF-kappa B and transcriptional control of renal epithelial-inducihle nitric oxide synthase. Kidney Int 1995; 48:674-682
49. Asano K, Chee CBE, Gaston B, et al: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A 1994; 91:10089-10093
50. Bobbins RA, Barnes PJ, Springall DR, et al: Expression of inducible nitric oxide synthase in human lung epithelial cells. Biochem Biophys Res Commun 1994; 203:209-218
51. x generation by cultured small intestinal epithelial cells. Dig Dis Sci 1995; 40:1859-1865
52. Unno N, Menconi MJ, Smith M, et al: Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 1995; 23:1170-1176
53. Salzman AL, Denenberg AG, Ueta I, et al: Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996; 270:G565-G573
54. Cook HT, Bune AJ, Jansen AS, et al: Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci 1994; 87:179-186
55. Mercer DW, Smith GS, Cross JM, et al: Effects of lipopolysaccharide on intestinal injury: Potential role of nitric oxide and lipid peroxidation. J Surg Res 1996; 63:185-192
56. Chamulitrat W, Skrepnik NV, Spitzer JJ: Endotoxin-induced oxidative stress in the rat small intestine: Role of nitric oxide. Shock 1996; 5:217-222
57. Geller DA, Nussler AK, Di Silvio M, et al: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A 1993; 90:522-526
58. Balligand J-L, Ungureanu-Longrois D, Simmons WW, et al: Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 1994; 269:27580-27588
59. Schultz PJ, Archer SL, Rosenberg ME: Inducible nitric oxide synthase mRNA and activity in glomerular mesangial cells. Kidney Int 1994; 46:683-689
60. Chen K, Inoue M, Okada A: Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem Biophys Res Commun 1996; 224:703-708
61. Xie Q-W, Kashiwabara Y, Nathan C: Role of transcription factor NF-kB in induction of nitric oxide synthase. J Biol Chem 1994; 269:4705-4708
62. Xie Q-W, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J Exp Med 1993; 177:1779-1784
63. Evans T, Carpenter A, Cohen J: Inducible nitric oxide synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. J Biol Chem 1994; 219:563-569